20 Deaths in Japan Linked to Vasculitis Drug Tavneos

Twenty patients in Japan have died after being administered Tavneos, a drug for vasculitis developed by Amgen. Japanese health authorities and the drug's partner are advising patients to consult their doctors regarding its use.

16 May, 02:37 — 16 May, 12:23

Post Share

Why this matters

This story is significant as it involves potential adverse effects of a prescribed medication for a serious condition, vasculitis. The reported deaths, even without confirmed causation, raise concerns about drug safety and could impact patient trust and regulatory scrutiny of Tavneos.

Key entitiesTavneos Amgen Japanese pharmaceutical company (Nagano Prefecture)

The Story

What 4 sources agree on, dispute, and miss

What sources agree on

20 deaths in Japan have been reported following the administration of the vasculitis drug Tavneos
The drug is sold by a pharmaceutical company in Nagano Prefecture, Japan
The causal relationship between the drug and the deaths is currently unclear

Key claims3 agreed

✓

20 patients in Japan died after being administered Tavneos

agreed·seeking-alphaNHK Worldjapan-timeswsj

✓

The pharmaceutical company selling Tavneos stated that the causal relationship between the drug and the deaths is unknown

agreed·NHK Worldjapan-times

✓

Patients currently using Tavneos should consult their primary physician

agreed·NHK World

Coverage gaps

The specific advice for patients to consult their doctors regarding Tavneos use

ReportedNHK World

Missingseeking-alphajapan-timeswsj

The name of the Japanese pharmaceutical company distributing Tavneos

ReportedNHK World

Missingseeking-alphajapan-timeswsj

The Story

Analyzing sources…

Source Diversity

High (56/100)

4 sources30/33

Spectrum spread— 3/5 buckets covered17/33

Far L

Left1

Left (1)

japan-times

Center1

Center (1)

NHK World

Right2

Right (2)

seeking-alphawsj

Far R

Geographic diversity— 2 regions9/34

US2Japan2

Political spectrum

LeftCenterRight

japan-times

nhk

seeking-alpha

wsj

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

japan-timescentercenter-leftcautiousMostly FactualReports facts, emphasizes lack of clarity on causation

NHK WorldcentercenterneutralHighReports facts and company's advice to public

Coverage leans: center

The coverage is largely factual and neutral, focusing on reporting the incident without significant political framing or advocacy.

Sources

Showing 2 of 4 sources

japan-timesMostly Factual87d ago

Amgen’s Tavneos discouraged by Japanese partner after deaths

Twenty people in Japan died after taking Tavneos, though it's unclear whether the drug killed those people, a media report said.

Read full article →

seeking-alphaMixed86d ago

Amgen’s Tavneos reportedly linked to 20 deaths in Japan

Read full article →

Coverage Timeline

First report: wsj · 15 May, 20:13|Full coverage: 4 · 16h|Window: 16h

Left-leaningCenterRight-leaning

wsj15 May, 20:13First to report

20 People in Japan Died After Taking Amgen Drug - WSJ

6h later

japan-times16 May, 02:37

Amgen’s Tavneos discouraged by Japanese partner after deaths

3h later

NHK World16 May, 05:52

血管炎の薬投与後に患者20人死亡“使用の患者医師と相談を”

7h later

seeking-alpha16 May, 12:23Latest update

Amgen’s Tavneos reportedly linked to 20 deaths in Japan

Story evolution

The narrative evolved from simply reporting the deaths to including the drug distributor's official statement and advice to patients.

Initial ReportsMay 15 evening - May 16 early morning

Early reports from WSJ and Japan Times confirm 20 deaths linked to Tavneos, noting the lack of confirmed causation.

Company Statement & Public AdviceMay 16 morning

NHK reports the Japanese distributor's announcement of the deaths and their advice for patients to consult doctors.

Financial Market ReactionMay 16 midday

Seeking Alpha reports on the news, likely from a financial market perspective.

PERSPECTA

PERSPECTA

20 Deaths in Japan Linked to Vasculitis Drug Tavneos

Why this matters

The Story

What sources agree on

Key claims3 agreed

Coverage gaps

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

Amgen’s Tavneos discouraged by Japanese partner after deaths

Amgen’s Tavneos reportedly linked to 20 deaths in Japan

Coverage Timeline

20 People in Japan Died After Taking Amgen Drug - WSJ

Amgen’s Tavneos discouraged by Japanese partner after deaths

血管炎の薬投与後に患者20人死亡“使用の患者医師と相談を”

Amgen’s Tavneos reportedly linked to 20 deaths in Japan

Story evolution

Related Stories

Serbia Experiences High UV Index and Heatwave, Emphasizing Sun Protection

German Schools Struggle with High Temperatures, Impacting Learning

Essential Items for a Beach First-Aid Kit

Therapist Reveals Four Unexpected Reasons Couples Seek Therapy

PERSPECTA

Why this matters

Story evolution

The Story

What sources agree on

Key claims3 agreed

Coverage gaps

Political spectrum

Coverage matrix

20 Deaths in Japan Linked to Vasculitis Drug Tavneos

Why this matters

The Story

What sources agree on

Key claims3 agreed

Coverage gaps

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

Amgen’s Tavneos discouraged by Japanese partner after deaths

Amgen’s Tavneos reportedly linked to 20 deaths in Japan

Coverage Timeline

20 People in Japan Died After Taking Amgen Drug - WSJ

Amgen’s Tavneos discouraged by Japanese partner after deaths

血管炎の薬 投与後に患者20人死亡“使用の患者 医師と相談を”

Amgen’s Tavneos reportedly linked to 20 deaths in Japan

Story evolution

Related Stories

Serbia Experiences High UV Index and Heatwave, Emphasizing Sun Protection

German Schools Struggle with High Temperatures, Impacting Learning

Essential Items for a Beach First-Aid Kit

Therapist Reveals Four Unexpected Reasons Couples Seek Therapy

Why this matters

Story evolution

The Story

What sources agree on

Key claims3 agreed

Coverage gaps

Political spectrum

Coverage matrix

血管炎の薬投与後に患者20人死亡“使用の患者医師と相談を”